Effects of immunosuppressive and immunostimulative treatment on pancreatic injury and mortality in severe acute experimental pancreatitis

Pancreas

Volumn 33, Issue 2, 2006, Pages 174-183

  Rau, Bettina M ^a   Krüger, Colin M ^a   Hasel, Cornelia ^b   Oliveira, Vilma ^a   Rubie, Claudia ^a   Beger, Hans G ^b   Schilling, Martin K ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Apoptosis; Experimental study; FK506; Immunomodulation; Interferon gamma; Necrosis; Severe acute pancreatitis

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2; MYELOPEROXIDASE; RECOMBINANT GAMMA INTERFERON; SODIUM CHLORIDE; TACROLIMUS; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; EXPERIMENTAL MODEL; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; IMMUNIZATION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; MORTALITY; NEUTROPHIL; NONHUMAN; PANCREAS INJURY; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; RAT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-2; MALE; NECROSIS; PANCREAS; PANCREATITIS, ACUTE NECROTIZING; RATS; RATS, WISTAR; RNA, MESSENGER; TACROLIMUS; TAUROCHOLIC ACID; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746845252     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000226895.16817.a1     Document Type: Article

References (49)

1. Lerch MM, Adler G. Experimental animal models of acute pancreatitis. Int J Pancreatol. 1994;15:159-170.
2. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol. 1988;3:105-112.
3. McKay CJ, Gallagher G, Brooks B, et al. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg. 1996;83:919-923.
4. Mora A, Perez-Mateo M, Viedma JA, et al. Activation of cellular immune response in acute pancreatitis. Gut. 1997;40:794-797.
5. Heresbach D, Letourneur JP, Bahon I, et al. Value of early blood Th-1 cytokine determination in predicting severity of acute pancreatitis. Scand J Gastroenterol. 1998;33:554-560.
6. Mayer J, Rau B, Gansauge F, et al. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut. 2000;47:546-552.
7. Dugernier TL, Laterre PF, Wittebole X, et al. Compartmentalization of the inflammatory response during acute pancreatitis. Correlation with local and systemic complications. Am J Respir Crit Care Med. 2003;168:148-157.
8. Sandoval D, Gukovskaya AS, Reavey P, et al. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology. 1996;111:1081-1091.
9. Frossard JL, Saluja A, Bhagat L, et al. The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology. 1998;116:694-701.
10. Bhatia M, Saluja AK, Hofbauer B, et al. The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury. Int J Pancreatol. 1998;24:77-83.
11. Kyriakides C, Jasleen J, Wang Y, et al. Neutrophils, not complement, mediate the mortality of experimental hemorrhagic pancreatitis. Pancreas. 2001;22:40-46.
12. Wittel UA, Rau B, Gansauge F, et al. Influence of PMN leukocyte-mediated pancreatic damage on the systemic immune response in severe acute pancreatitis in rats. Dig Dis Sci. 2004;49:1348-1357.
13. Demols A, Le Moine O, Desalle F, et al. DC4(+) T cells play an important role in acute experimental pancreatitis in mice. Gastroenterology. 2000;118:582-590.
14. Mayer J, Laine VJO, Rau B, et al. Systemic lymphocyte activation modulates the severity of diet-induced acute pancreatitis in mice. Pancreas. 1999;19:62-68.
15. Yang J, Denham W, Tracey KJ, et al. The physiologic consequences of macrophage pacification during severe acute pancreatitis. Shock. 1998;10:169-175.
16. Mikami Y, Takeda K, Shibuya K, et al. Do peritoneal macrophages play an essential role in the progression of acute pancreatitis in rats? Pancreas. 2003;27:253-260.
17. Shifrin AL, Chirmule N, Zhang Y, et al. Macrophage ablation attenuates adenoviral vector-induced pancreatitis. Surgery. 2005;137:545-551.
18. Garcia-Sabrido JL, Valdecantos E, Bastida E, et al. The anergic state as a predictor of pancreatic sepsis. Zentralbl Chir. 1989;114:114-120.
19. Curley P, Nestor M, Collins K, et al. Decreased interleukin-2 production in murine acute pancreatitis: Potential for immunomodulation. Gastroenterology. 1996;110:583-588.
20. Richter A, Nebe T, Kattermann R, et al. Immune paralysis in acute pancreatitis - HLA-DR antigen expression on CD14+DR+ monocytes. Langenbecks Arch Chir. 1996;381:38-41.
21. Satoh A, Miura T, Satoh K, et al. Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Pancreas. 2002;25:245-250.
22. Pezzilli R, Billi P, Beltrandi E, et al. Impaired lymphocyte proliferation in human acute pancreatitis. Digestion. 1997;58:431-436.
23. Götzinger P, Sautner T, Spittler A, et al. Severe acute pancreatitis causes alterations in HLA-DR and CD14 expression on peripheral blood monocytes independently of surgical treatment. Eur J Surg. 2000;166:628-632.
24. Kylänpää-Bäck ML, Takala A, Kemppainen E, et al. Cellular markers of systemic inflammation and immune suppression in patients with organ failure due to severe acute pancreatitis. Scand J Gastroenterol. 2001;36:1100-1107.
25. Mentula P, Kylänpää-Bäck ML, Kemppainen E, et al. Decreased HLA (human leukocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Clin Sci (Lond). 2003;105:409-417.
26. Yu WK, Li WQ, Li N, et al. Mononuclear histocompatibility leukocyte antigen-DR expression in the early phase of acute pancreatitis. Pancreatology. 2004;4:233-243.
27. Dumont FJ. FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem. 2000;7:731-748.
28. Thomson AW, Bonham CA, Zeevi A. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit. 1995;17:584-591.
29. Mayer LM, Laine VJ, Gezgin A, et al. Single doses of FK506 and OKT3 reduce severity in early experimental acute pancreatitis. Eur J Surg. 2000;166:734-741.
30. Echigo Y, Inoue K, Kogire M, et al. Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice. Arch Surg. 1995;130:64-68.
31. Frucht DM, Fukao T, Bogdan C, et al. IFN-gamma production by antigen presenting cells: mechanisms emerge. Trends Immunol. 2001;22:556-560.
32. Schröder K, Hertzog PJ, Ravasi T, et al. Interferon-F: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75:163-189.
33. Kylanpaa ML, Mentula P, Kemppainen E, et al. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro. Pancreas. 2005;31:23-27.
34. Richter A, Lorenz D, Ockert S, et al. Activation of the MHC-class II expression with Interferon-F in acute pancreatitis in rats. Langenbecks Archiv Chir (Forumband). 1997;(suppl 1):399-402.
35. Rau B, Paszkowski A, Lillich S, et al. Differential effects of caspase-1/interleukin-1β-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest. 2001;81:1001-1013.
36. Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209.
37. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
38. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
39. Schoonjans F, Zalata A, Depuydt CE, et al. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed. 1995;48:257-262.
40. Shaposhnikov IG, Reshetnikov EA, Miasnikova NA, et al. Role of immunosuppression in the complex treatment of acute pancreatitis. Khirurgiia (Mosk). 1980;1:85-189.
41. Foitzik T, Forgacs B, Ryschich E, et al. Effect of different immunosuppressive agents on acute pancreatitis: a comparative study in an improved animal model. Transplantation. 1998;65:1030-1036.
42. Bhatia M, Neoptolemos JP, Slavin J. Inflammatory mediators as therapeutic targets in acute pancreatitis. Curr Opin Investig Drugs. 2001;2:496-501.
43. Curley PJ, MaMahon MJ, Lancaster F, et al. Reduction in circulating levels of CD4 positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin-6 and disease severity. Br J Surg. 1993;80:1312-1315.
44. Uehara S, Gothoh K, Handa H, et al. Immune function in patients with acute pancreatitis. J Gastroenterol Hepatol. 2003;18:363-370.
45. Nierhaus A, Montag B, Timmler N, et al. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med. 2003;29:646-651.
46. Widdison AL, Karanjia ND, Alvarez C, et al. Influence of levamisole on pancreatic infection in acute pancreatitis. Am J Surg. 1992;163:100-103.
47. Gukovskaya AS, Gukovsky I, Zaninovic V, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest. 1997;100:1853-1862.
48. Krause I, Valesini G, Scrivo R, et al. Autoimmune aspects of cytokine and anticytokine therapies. Am J Med. 2003;115:390-397.
49. Snydman DR, Sullican B, Gill M, et al. Nosocomial sepsis associated with interleukin-2. Ann Intern Med. 1990;112:102-107.